BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

24 hedge funds and large institutions have $19.4M invested in ProShares Ultra NASDAQ Biotechnology in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
8
Increased
6
Reduced
8
Closed
11
Calls
$24.9M
Puts
$51.2M
Net Calls
-$26.2M
Net Calls Change
-$2.22M

Top Buyers

1
VF
1
Virtu Financial
New York
$3.24M
2
AIG
2
American International Group
New York
$1.15M
3
Citadel Advisors
3
Citadel Advisors
Florida
$3.76M
4
WSTAM
4
Wilbanks Smith & Thomas Asset Management
Virginia
$474K
5
BHA
5
Beech Hill Advisors
New York
$437K

Top Sellers

1
AP
1
Advisors Preferred
Maryland
$0
2
PCM
2
Prelude Capital Management
New York
$379K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
OPPM
4
Opus Point Partners Management
New York
$1.91M
5
Jane Street
5
Jane Street
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
26
Jane Street
New York
– -$664K -7,346 Closed
VKH
27
Virtu KCG Holdings
New York
– -$591K -6,537 Closed
Millennium Management
28
Millennium Management
New York
– -$324K -3,585 Closed
Cambridge Investment Research Advisors
29
Cambridge Investment Research Advisors
Iowa
– -$280K -3,100 Closed
CWM
30
Concert Wealth Management
California
– -$271K -2,997 Closed
S
31
SignatureFD
Georgia
– -$144K -1,588 Closed
Barclays
32
Barclays
United Kingdom
– -$90K -1,000 Closed
Simplex Trading
33
Simplex Trading
Illinois
– -$84K -933 Closed
WA
34
Waverly Advisors
Alabama
– -$5K -60 Closed
1
2